Researcher
Annelies Debucquoy
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Jan 2006 → Today - Department of Imaging & Pathology (Department)
Member
From13 Aug 2004 → 31 Dec 2005
Projects
1 - 4 of 4
- Organ preserving strategies in rectal cancerFrom10 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimisation of the treatment of rectal cancer in patients by combining preoperative chemoradiation with angiogenesis inhibitors.From1 Jan 2012 → 31 Dec 2014Funding: FWO research grant KAN
- Optimisation of rectal cancer treatment by response prediction and the addition of molecular targeted agents.From1 Oct 2010 → 3 Apr 2016Funding: FWO fellowships
- Optimization of the use of tyrosine kinase receptor inhibitors in the preoperative treatment for rectal cancer.From1 Mar 2010 → 28 Feb 2011Funding: BOF - Other initiatives
Publications
1 - 10 of 34
- Editorial: Biobanks as Essential Tools for Translational Research: The Belgian Landscape(2020)
Authors: Annelies Debucquoy
- Extending the Minimum Information About BIobank Data Sharing Terminology to Describe Samples, Sample Donors, and Events(2020)
Authors: Niina Eklund, Ny Haingo Andrianarisoa, Esther van Enckevort, Gabriele Anton, Annelies Debucquoy, Heimo Mueller, Linda Zaharenko, Caecilia Engels, Lars Ebert, Michael Neumann, et al.
Pages: 155 - 164 - Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics(2020)
Authors: Philippe Bulens, Annelies Debucquoy, Vincent Vandecaveye, Eric Van Cutsem, Albert Wolthuis, Karin Haustermans
Pages: 246 - 252 - Treatment individualisation for patients with rectal cancer: towards an organ-preserving approach(2019)
Authors: Philippe Bulens, Karin Haustermans, Annelies Debucquoy
- The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients(2018)
Authors: Karin Haustermans, Annelies Debucquoy, Eric Van Cutsem
Pages: 1012 - + - Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer(2018)
Authors: Philippe Bulens, Karin Haustermans, Annelies Debucquoy, Vincent Vandecaveye
Pages: 437 - 442 - Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation(2018)
Authors: Annelies Debucquoy, Karin Haustermans
Pages: 659 - 670 - Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer(2017)
Authors: Annelies Debucquoy, Christophe Deroose, Vincent Vandecaveye, Eric Van Cutsem, Albert Wolthuis, Xavier Sagaert, Karin Haustermans
Pages: 104 - 109 - Survival among clinical stage I-III rectal cancer patients with different preoperative and postoperative treatments: a population-based comparison(2016)
Authors: Ines Joye, Annelies Debucquoy, Freddy Penninckx, Karin Haustermans
Pages: 35 - 41 - Tumour regression in rectal cancer: What is the most robust tumour regression grade system?(2016)
Authors: Linde De Smedt, Sander Palmans, FM Bosisio, F Ballaux, K Wetzels, I Joye, Annelies Debucquoy, André D'Hoore, Karin Haustermans, Xavier Sagaert
Pages: S149 - S149